A study for a 32 year old woman who takes L-2,6-Diaminohexanoic Acid - from FDA reports


Summary

350 females aged 32 (±5) who take the same drug are studied. This is a personalized study for a 32 year old female patient who has Gallstones. The study is created by eHealthMe based on reports from FDA.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>


On Sep, 12, 2017

350 females aged 32 (±5) who take L-2,6-Diaminohexanoic Acid are studied.


Number of reports submitted per year:

L-2,6-Diaminohexanoic Acid for a 32-year old woman.

Information of the patient in this study:

  • Age: 32
  • Gender: female
  • Conditions: Gallstones
  • Drugs taken:
    • L-2,6-Diaminohexanoic Acid (lysine)

eHealthMe real world results:

Comparison with this patient's adverse outcomes:

  • Abdominal Pain: 0 (0% of females aged 32 (±5) who take the drug)
  • Nausea: 0 (0% of females aged 32 (±5) who take the drug)
  • Low Back Pain: 0 (0% of females aged 32 (±5) who take the drug)
  • Vomiting: 0 (0% of females aged 32 (±5) who take the drug)

As an adverse outcome could be a symptom of a condition, additional studies are listed to help identify the cause: for example, regardless of which drug is taken, how many female HBP patients aged 50 (±5) have nausea

As an adverse outcome could be a side effect of a drug, additional studies are listed to help identify the cause: for example, how many female Aspirin users aged 50 (±5) have nausea

Most common side effects over time

< 1 month:
  • seizures
  • lung disorder
  • gastroenteritis viral
  • infective pulmonary exacerbation of cystic fibrosis
  • respiratory acidosis
1 - 6 months:
  • respiratory disorder
  • lung transplant
  • infective pulmonary exacerbation of cystic fibrosis
  • forced expiratory volume decreased
  • productive cough
  • death
  • pneumonia
  • nausea
  • weight decreased
  • fever
6 - 12 months:
  • respiratory acidosis
  • cystic fibrosis
  • pneumonia
  • lung transplant
  • cardiopulmonary failure
1 - 2 years:
  • pneumonia
  • infective pulmonary exacerbation of cystic fibrosis
  • death
  • acute respiratory failure
  • lung transplant
2 - 5 years:
  • death
  • lung transplant
  • cystic fibrosis
  • rhinovirus infection
  • fall
  • hip fracture
  • respiratory syncytial virus infection
  • pneumonia
  • respiratory acidosis
  • graft versus host disease
5 - 10 years:
  • death
10+ years:
n/a
not specified:
  • death
  • cystic fibrosis
  • infective pulmonary exacerbation of cystic fibrosis
  • pneumonia
  • lung disorder
  • malaise
  • lung transplant
  • pain
  • nausea
  • breathing difficulty

Top conditions involved for these people *:

  • Cystic Fibrosis (175 people, 50.00%)
  • Pseudomonas Infection (83 people, 23.71%)
  • Cystic Fibrosis Lung (43 people, 12.29%)
  • Narcolepsy (17 people, 4.86%)
  • Birth Control (17 people, 4.86%)

Top co-used drugs for these people *:

  • Pulmozyme (20 people, 5.71%)
  • Xyrem (18 people, 5.14%)
  • Vitamin D3 (12 people, 3.43%)
  • Vitamin D (12 people, 3.43%)
  • Humira (12 people, 3.43%)

* Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Subscribe to the study: get notified of updates to the study.

You can also:

Expand the study to include reports from both FDA and eHealthMe

Expand this study to include FDA and eHealthMe reports

What are the drugs?

What are the conditions?

What are the symtoms?

Could your drugs cause:

Could your conditions cause:

Related studies:

Can you answer these questions?

More questions for: Low back pain, Gallstones, Abdominal pain, Vomiting, L-2,6-diaminohexanoic acid, Nausea

You may be interested in these reviews

More reviews for: Low back pain, Gallstones, Abdominal pain, Vomiting, L-2,6-diaminohexanoic acid, Nausea